ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Internal Medicine

Top Internal Medicine Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BERNARD PERLMAN MD

Internal Medicine

8,099

$500K

205
181 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $69

PAUL LAPRISE M.D.

Internal Medicine

8,091

$524K

490
402 are 65+

2%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $69

DEVARAJAN MANU M.D.

Internal Medicine

7,990

$560K

576
423 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $69

MARK CIENIAWSKI M.D.

Internal Medicine

7,948

$532K

325
137 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $69

SHERRI DUMONT D.O.

Internal Medicine

7,932

$681K

248
200 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $69

DOUGLAS TRENKLE DO

Internal Medicine

7,918

$750K

319
259 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 24%

$95
Average prescription price

Avg: $69

RAMON CHELEUITTE MD

Internal Medicine

7,911

$645K

371
298 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$82
Average prescription price

Avg: $69

PAMELA ROSS

Internal Medicine

7,868

$490K

404
310 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $69

DONALD SMITH M.D.

Internal Medicine

7,860

$531K

595
535 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $69

DONALD DUBOIS M.D.

Internal Medicine

7,808

$417K

440
377 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $69

RICHARD ENGEL MD

Internal Medicine

7,725

$443K

562
453 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $69

JENNIFER PYENTA DO

Internal Medicine

7,508

$585K

510
363 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $69

KATARINA LATKOVICH MD

Internal Medicine

7,466

$471K

420
262 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $69

STEPHEN GOSS D.O.

Internal Medicine

7,404

$485K

421
278 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $69

EDWIN TAN MD

Internal Medicine

7,404

$529K

456
296 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $69

MYRON KRUEGER MD

Internal Medicine

7,373

$463K

275
229 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $69

PETER HARBAGE MD

Internal Medicine

7,309

$409K

413
354 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $69

NANCY KNAPP M.D.

Internal Medicine

7,277

$331K

252
166 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $69

BEENA SATTAR MD

Internal Medicine

7,078

$461K

322
264 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $69

ROBERT CARPENTER M.D.

Internal Medicine

7,067

$733K

362
294 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$104
Average prescription price

Avg: $69

LISE CLOUTIER

Internal Medicine

6,914

$500K

499
391 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $69

ALBERT ANIEL MD

Internal Medicine

6,875

$468K

465
367 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $69

NADEEM ALI M.D.

Internal Medicine

6,807

$410K

348
191 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $69

HAL COHEN D.O.

Internal Medicine

6,795

$574K

293
205 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$85
Average prescription price

Avg: $69

UZMA NAAZ MD

Internal Medicine

6,753

$385K

312
213 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank